Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03748953
What this trial is testing

Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 37
Very early researchLooking for participantsNCT02982902
What this trial is testing

T Cell Therapy of Opportunistic Cytomegalovirus Infection

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantOpportunistic Infections
Mari Dallas 20
Early research (Phase 1)Ended earlyNCT00093704
What this trial is testing

Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma

Who this might be right for
LymphomaLymphoproliferative Disorder
Jonsson Comprehensive Cancer Center 1
Very early researchStudy completedNCT03131934
What this trial is testing

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

Who this might be right for
Post-transplant Lymphoproliferative DiseaseTransplant-Related Hematologic Malignancy
University College, London 4
Testing effectiveness (Phase 2)Looking for participantsNCT06483100
What this trial is testing

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 65
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Large-scale testing (Phase 3)UnknownNCT04799314
What this trial is testing

PD-1 Inhibitor Tislelizumab Maintenance Therapy in R/R DLBCL Patients After ASCT

Who this might be right for
Lymphoma, Large B-Cell, DiffuseTransplantationChemotherapy
Ruijin Hospital 132
Testing effectiveness (Phase 2)Ended earlyNCT00984165
What this trial is testing

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hodgkin's LymphomaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemias+1 more
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT00398411
What this trial is testing

Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

Who this might be right for
Hodgkin DiseaseNon-Hodgkin LymphomaMultiple Myeloma+1 more
University of Cologne 66
Testing effectiveness (Phase 2)Study completedNCT01827137
What this trial is testing

WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Sellas Life Sciences Group 20
Testing effectiveness (Phase 2)Study completedNCT00460694
What this trial is testing

Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+4 more
Singapore General Hospital 24
Early research (Phase 1)Ended earlyNCT01116154
What this trial is testing

Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more
City of Hope Medical Center 30
Not applicableStudy completedNCT00534118
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Roswell Park Cancer Institute 39
Testing effectiveness (Phase 2)Study completedNCT03133221
What this trial is testing

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

Who this might be right for
Non Hodgkin LymphomaFollicular LymphomaIndolent Lymphoma+6 more
University of Maryland, Baltimore 17
Testing effectiveness (Phase 2)Study completedNCT00564200
What this trial is testing

MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 30
Not applicableStudy completedNCT01171430
What this trial is testing

"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 104
Testing effectiveness (Phase 2)Study completedNCT02120157
What this trial is testing

Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

Who this might be right for
Myeloablative ConditioningHLA-mismatched Bone Marrow TransplantationGraft Survival+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT01481272
What this trial is testing

Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Polish Lymphoma Research Group 77
Early research (Phase 1)Study completedNCT00660166
What this trial is testing

Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions

Who this might be right for
LymphomaMyelomaLeukemia
Tufts Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT00089596
What this trial is testing

Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+2 more
ViaCell 10
Next Page